Zhengye Biotechnology Holding Stock Market Value
| ZYBT Stock | 1.17 0.02 1.74% |
| Symbol | Zhengye |
Zhengye Biotechnology Company Valuation
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zhengye Biotechnology. If investors know Zhengye will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zhengye Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.80) | Earnings Share (0.06) | Revenue Per Share | Quarterly Revenue Growth (0.34) | Return On Assets |
The market value of Zhengye Biotechnology is measured differently than its book value, which is the value of Zhengye that is recorded on the company's balance sheet. Investors also form their own opinion of Zhengye Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Zhengye Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zhengye Biotechnology's market value can be influenced by many factors that don't directly affect Zhengye Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zhengye Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zhengye Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zhengye Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Zhengye Biotechnology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Zhengye Biotechnology's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Zhengye Biotechnology.
| 01/17/2025 |
| 01/12/2026 |
If you would invest 0.00 in Zhengye Biotechnology on January 17, 2025 and sell it all today you would earn a total of 0.00 from holding Zhengye Biotechnology Holding or generate 0.0% return on investment in Zhengye Biotechnology over 360 days. Zhengye Biotechnology is related to or competes with Quoin Pharmaceuticals, Impact BioMedical, Pasithea Therapeutics, Addex Therapeutics, Matinas BioPharma, PharmaCyte Biotech, and Alaunos Therapeutics. Zhengye Biotechnology is entity of United States More
Zhengye Biotechnology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Zhengye Biotechnology's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Zhengye Biotechnology Holding upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.28) | |||
| Maximum Drawdown | 34.41 | |||
| Value At Risk | (8.93) | |||
| Potential Upside | 4.76 |
Zhengye Biotechnology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zhengye Biotechnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Zhengye Biotechnology's standard deviation. In reality, there are many statistical measures that can use Zhengye Biotechnology historical prices to predict the future Zhengye Biotechnology's volatility.| Risk Adjusted Performance | (0.19) | |||
| Jensen Alpha | (1.41) | |||
| Total Risk Alpha | (1.86) | |||
| Treynor Ratio | (0.92) |
Zhengye Biotechnology Backtested Returns
Zhengye Biotechnology shows Sharpe Ratio of -0.27, which attests that the company had a -0.27 % return per unit of risk over the last 3 months. Zhengye Biotechnology exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Zhengye Biotechnology's Market Risk Adjusted Performance of (0.91), mean deviation of 3.55, and Standard Deviation of 4.94 to validate the risk estimate we provide. The firm maintains a market beta of 1.4, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Zhengye Biotechnology will likely underperform. At this point, Zhengye Biotechnology has a negative expected return of -1.31%. Please make sure to check out Zhengye Biotechnology's standard deviation, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Zhengye Biotechnology performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.52 |
Good reverse predictability
Zhengye Biotechnology Holding has good reverse predictability. Overlapping area represents the amount of predictability between Zhengye Biotechnology time series from 17th of January 2025 to 16th of July 2025 and 16th of July 2025 to 12th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Zhengye Biotechnology price movement. The serial correlation of -0.52 indicates that about 52.0% of current Zhengye Biotechnology price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.52 | |
| Spearman Rank Test | -0.68 | |
| Residual Average | 0.0 | |
| Price Variance | 8.4 |
Zhengye Biotechnology lagged returns against current returns
Autocorrelation, which is Zhengye Biotechnology stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Zhengye Biotechnology's stock expected returns. We can calculate the autocorrelation of Zhengye Biotechnology returns to help us make a trade decision. For example, suppose you find that Zhengye Biotechnology has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Zhengye Biotechnology regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Zhengye Biotechnology stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Zhengye Biotechnology stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Zhengye Biotechnology stock over time.
Current vs Lagged Prices |
| Timeline |
Zhengye Biotechnology Lagged Returns
When evaluating Zhengye Biotechnology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Zhengye Biotechnology stock have on its future price. Zhengye Biotechnology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Zhengye Biotechnology autocorrelation shows the relationship between Zhengye Biotechnology stock current value and its past values and can show if there is a momentum factor associated with investing in Zhengye Biotechnology Holding.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Zhengye Stock Analysis
When running Zhengye Biotechnology's price analysis, check to measure Zhengye Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zhengye Biotechnology is operating at the current time. Most of Zhengye Biotechnology's value examination focuses on studying past and present price action to predict the probability of Zhengye Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zhengye Biotechnology's price. Additionally, you may evaluate how the addition of Zhengye Biotechnology to your portfolios can decrease your overall portfolio volatility.